Literature DB >> 17878501

Major depressive disorder and comorbid cardiac disease: is there a depressive subtype with greater cardiovascular morbidity? Results from the STAR*D study.

Renerio Fraguas1, Dan V Iosifescu, Jonathan Alpert, Stephen R Wisniewski, Jennifer L Barkin, Madhukar H Trivedi, A John Rush, Maurizio Fava.   

Abstract

The authors conducted exploratory analyses to determine whether specific symptoms of major depressive disorder (MDD) are associated with cardiac disease in 4,041 outpatients at baseline in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. MDD was diagnosed with the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition; depressive symptoms were evaluated with the 30-item Inventory of Depressive Symptomatology, Clinician-Rated; and cardiac disease, with the Cumulative Illness Rating Scale. After adjustments for gender, age, ethnicity, education, and employment status, sympathetic arousal and early-morning insomnia were significantly associated with cardiac disease. Prospective studies are warranted to confirm these results.

Entities:  

Mesh:

Year:  2007        PMID: 17878501     DOI: 10.1176/appi.psy.48.5.418

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  12 in total

Review 1.  Is there a high-risk subtype of depression in patients with coronary heart disease?

Authors:  Robert M Carney; Kenneth E Freedland
Journal:  Curr Psychiatry Rep       Date:  2012-02       Impact factor: 5.285

2.  Depressive subtype a predictor of cardiovascular morbidity.

Authors:  Meera Narasimhan; Prakash Masand
Journal:  Curr Psychiatry Rep       Date:  2008-06       Impact factor: 5.285

3.  Functional capacity is a better predictor of coronary heart disease than depression or abnormal sleep duration in Black and White Americans.

Authors:  Oladipupo Olafiranye; Girardin Jean-Louis; Mike Antwi; Ferdinand Zizi; Raphael Shaw; Perry Brimah; Gbenga Ogedegbe
Journal:  Sleep Med       Date:  2012-03-31       Impact factor: 3.492

4.  Atypical depression and double depression predict new-onset cardiovascular disease in U.S. adults.

Authors:  Stephanie M Case; Manisha Sawhney; Jesse C Stewart
Journal:  Depress Anxiety       Date:  2017-06-22       Impact factor: 6.505

5.  STAR*D: revising conventional wisdom.

Authors:  A John Rush; Diane Warden; Stephen R Wisniewski; Maurizio Fava; Madhukar H Trivedi; Bradley N Gaynes; Andrew A Nierenberg
Journal:  CNS Drugs       Date:  2009-08       Impact factor: 5.749

6.  Anxiety and cardiovascular symptoms: the modulating role of insomnia.

Authors:  O Olafiranye; G Jean-Louis; C Magai; F Zizi; C D Brown; M Dweck; J S Borer
Journal:  Cardiology       Date:  2009-11-12       Impact factor: 1.869

7.  Quantifying between-cohort and between-sex genetic heterogeneity in major depressive disorder.

Authors:  Maciej Trzaskowski; Divya Mehta; Wouter J Peyrot; David Hawkes; Daniel Davies; David M Howard; Kathryn E Kemper; Julia Sidorenko; Robert Maier; Stephan Ripke; Manuel Mattheisen; Bernhard T Baune; Hans J Grabe; Andrew C Heath; Lisa Jones; Ian Jones; Pamela A F Madden; Andrew M McIntosh; Gerome Breen; Cathryn M Lewis; Anders D Børglum; Patrick F Sullivan; Nicholas G Martin; Kenneth S Kendler; Douglas F Levinson; Naomi R Wray
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-02-01       Impact factor: 3.568

8.  Fourth revolution in psychiatry - Addressing comorbidity with chronic physical disorders.

Authors:  Shiv Gautam
Journal:  Indian J Psychiatry       Date:  2010-07       Impact factor: 1.759

9.  Routine screening for depression in patients with coronary heart disease never mind.

Authors:  Roy C Ziegelstein; Brett D Thombs; James C Coyne; Peter de Jonge
Journal:  J Am Coll Cardiol       Date:  2009-09-01       Impact factor: 24.094

Review 10.  Depression in the medically ill: diagnostic and therapeutic implications.

Authors:  Meera Narasimhan; Jeffrey D Raynor; Ashley Blackmon Jones
Journal:  Curr Psychiatry Rep       Date:  2008-06       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.